The Discourse Profile in Corticobasal Syndrome: A Comprehensive Clinical and Biomarker Approach

Imagem de Miniatura
Arquivos
art_ALMEIDA_The_Discourse_Profile_in_Corticobasal_Syndrome_A_Comprehensive_2022.PDF (366.9 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
CARTHERY-GOULART, Maria Teresa
CECCHINI, Mario Amore
Citação
BRAIN SCIENCES, v.12, n.12, article ID 1705, 18p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of this study was to characterize the oral discourse of CBS patients and to verify whether measures obtained during a semi-spontaneous speech production could differentiate CBS patients from controls. A second goal was to compare the performance of patients with CBS probably due to Alzheimer's disease (CBS-AD) pathology and CBS not related to AD (CBS-non-AD) in the same measures, based on the brain metabolic status (FDG-PET) and in the presence of amyloid deposition (amyloid-PET). Results showed that CBS patients were significantly different from controls in speech rate, lexical level, informativeness, and syntactic complexity. Discursive measures did not differentiate CBS-AD from CBS-non-AD. However, CBS-AD displayed more lexical-semantic impairments than controls, a profile that is frequently reported in patients with clinical AD and the logopenic variant of primary progressive aphasia (lvPPA). CBS-non-AD presented mainly with impairments related to motor speech disorders and syntactic complexity, as seen in the non-fluent variant of PPA.
Palavras-chave
corticobasal syndrome, corticobasal degeneration, connected speech, language, discourse, spontaneous speech, positron emission tomography, amyloid-PET
URI
https://observatorio.fm.usp.br/handle/OPI/51533
Referências
  1. Abe Y, 2016, DEMENT GER COGN D EX, V6, P133, DOI 10.1159/000443329
  2. Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1
  3. Ash S, 2013, NEUROLOGY, V81, P329, DOI 10.1212/WNL.0b013e31829c5d0e
  4. Boschi V, 2017, FRONT PSYCHOL, V8, P1, DOI 10.3389/fpsyg.2017.00269
  5. Bose A, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.707628
  6. Brandão Lenisa, 2009, Psychol. Neurosci., V2, P147, DOI 10.3922/j.psns.2009.2.006
  7. Burrell JR, 2014, MOVEMENT DISORD, V29, P684, DOI 10.1002/mds.25872
  8. Burrell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061025
  9. Camozzato AL, 2008, INT PSYCHOGERIATR, V20, P383, DOI 10.1017/S1041610207006254
  10. Canu E, 2020, NEUROLOGY, V94, pE1062, DOI [10.1212/WNL.0000000000009064, 10.1212/WNL.0000000000008879]
  11. Cassidy Adam, 2016, Pract Neurol, V16, P317, DOI 10.1136/practneurol-2015-001354
  12. Catricala E, 2020, NEUROLOGY, V95, pE2816, DOI 10.1212/WNL.0000000000010967
  13. Cesar KG, 2017, INT PSYCHOGERIATR, V29, P1345, DOI 10.1017/S1041610217000734
  14. Chahine Lama M, 2014, Neurol Clin Pract, V4, P304
  15. Chaves MLF, 2007, ALZ DIS ASSOC DIS, V21, P210
  16. Coutinho AM, 2020, EUR J NUCL MED MOL I, V47, P2666, DOI 10.1007/s00259-020-04714-0
  17. Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S
  18. Almeida Isabel Junqueira de, 2021, Dement. neuropsychol., V15, P16, DOI 10.1590/1980-57642021dn15-010002
  19. de Lira JO, 2011, INT PSYCHOGERIATR, V23, P404, DOI 10.1017/S1041610210001092
  20. Di Stefano F, 2016, ALZHEIMERS DEMENT, V12, P786, DOI 10.1016/j.jalz.2016.02.005
  21. Dipper L.T., 2017, ADV SPEECH LANGUAGE, P4
  22. Dodich A, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.102009
  23. Drummond C, 2019, AGING-US, V11, P9188, DOI 10.18632/aging.102391
  24. Duffy JR, 2014, APHASIOLOGY, V28, P1004, DOI 10.1080/02687038.2013.869307
  25. Faroqi-Shah Y, 2020, J COMMUN DISORD, V85, DOI 10.1016/j.jcomdis.2020.105994
  26. Filiou RP, 2020, APHASIOLOGY, V34, P702, DOI 10.1080/02687038.2019.1608502
  27. Fraser KC, 2016, J ALZHEIMERS DIS, V49, P407, DOI 10.3233/JAD-150520
  28. Fraser KC, 2014, CORTEX, V55, P43, DOI 10.1016/j.cortex.2012.12.006
  29. Frattali CM, 2000, NEUROLOGY, V54, P990, DOI 10.1212/WNL.54.4.990
  30. Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213
  31. Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6
  32. Graham NL, 2016, DEMENT GER COGN D EX, V6, P407, DOI 10.1159/000448944
  33. Graham NL, 2003, NEUROLOGY, V61, P493, DOI 10.1212/01.WNL.0000081230.09863.ED
  34. Graham NL, 2003, MOVEMENT DISORD, V18, P1224, DOI 10.1002/mds.10536
  35. Grijalvo-Perez AM, 2014, SEMIN NEUROL, V34, P160, DOI 10.1055/s-0034-1381734
  36. Gross RG, 2010, COGN BEHAV NEUROL, V23, P1, DOI 10.1097/WNN.0b013e3181c5e2f8
  37. Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007
  38. Hu WT, 2009, MOVEMENT DISORD, V24, P1375, DOI 10.1002/mds.22574
  39. HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566
  40. Isella V, 2020, AM J ALZHEIMERS DIS, V35, DOI 10.1177/1533317520922390
  41. Josephs KA, 2008, CURR OPIN NEUROL, V21, P688, DOI 10.1097/WCO.0b013e3283168ddd
  42. Kemmerer D., 2015, COGNITIVE NEUROSCIEN
  43. Kertesz A, 2000, NEUROLOGY, V55, P1368, DOI 10.1212/WNL.55.9.1368
  44. Kertesz A., 2007, W APHASIA BATTERY RE
  45. Lavoie M, 2021, INT J LANG COMM DIS, V56, P1074, DOI 10.1111/1460-6984.12660
  46. Lee SE, 2011, ANN NEUROL, V70, P327, DOI 10.1002/ana.22424
  47. Lima Tatiane Machado, 2014, Rev. CEFAC, V16, P1168, DOI 10.1590/1982-021620147513
  48. Lin CY, 2014, DEMENT GERIATR COGN, V37, P86, DOI [10.1159/000354359, 10.1159/000360695]
  49. Magdalinou NK, 2018, NEUROCASE, V24, P204, DOI 10.1080/13554794.2018.1527368
  50. Mathew R, 2012, J NEUROL NEUROSUR PS, V83, P405, DOI 10.1136/jnnp-2011-300875
  51. Mathew R, 2011, DEMENT GERIATR COGN, V31, P254, DOI 10.1159/000327169
  52. McMonagle P, 2006, NEUROLOGY, V67, P1444, DOI 10.1212/01.wnl.0000240215.43492.01
  53. Neves MDB, 2014, CODAS, V26, P38, DOI 10.1590/s2317-17822014000100006
  54. NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338
  55. Ozsancak C, 2000, MOVEMENT DISORD, V15, P905, DOI 10.1002/1531-8257(200009)15:5<905::AID-MDS1022>3.0.CO;2-D
  56. Parjane N, 2021, J ALZHEIMERS DIS, V82, P33, DOI 10.3233/JAD-201132
  57. Parmera JB, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.702052
  58. Parmera JB, 2021, MOVEMENT DISORD, V36, P651, DOI 10.1002/mds.28373
  59. Parmera Jacy Bezerra, 2016, Dement. neuropsychol., V10, P267, DOI 10.1590/s1980-5764-2016dn1004003
  60. Peterson KA, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.675739
  61. Peterson KA, 2021, J NEUROL, V268, P796, DOI 10.1007/s00415-019-09463-1
  62. PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323
  63. SAFFRAN EM, 1989, BRAIN LANG, V37, P440, DOI 10.1016/0093-934X(89)90030-8
  64. Sajjadi SA, 2012, APHASIOLOGY, V26, P1219, DOI 10.1080/02687038.2012.710318
  65. Sajjadi SA, 2012, APHASIOLOGY, V26, P847, DOI 10.1080/02687038.2012.654933
  66. Sakae N, 2019, ALZHEIMERS DEMENT, V15, P1218, DOI 10.1016/j.jalz.2019.04.011
  67. Shelley BP, 2009, MOVEMENT DISORD, V24, P1593, DOI 10.1002/mds.22558
  68. Silagi ML, 2015, CLINICS, V70, P423, DOI 10.6061/clinics/2015(06)07
  69. Slegers A, 2021, CORTEX, V145, P160, DOI 10.1016/j.cortex.2021.09.010
  70. Slegers A, 2018, J ALZHEIMERS DIS, V65, P519, DOI 10.3233/JAD-170881
  71. Stark BC, 2021, AM J SPEECH-LANG PAT, V30, P491, DOI 10.1044/2020_AJSLP-19-00093
  72. Strand EA, 2014, J COMMUN DISORD, V51, P43, DOI 10.1016/j.jcomdis.2014.06.008
  73. Themistocleous C, 2021, AM J SPEECH-LANG PAT, V30, P466, DOI 10.1044/2020_AJSLP-19-00114
  74. Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129
  75. Yamane T, 2017, EUR J NUCL MED MOL I, V44, P850, DOI 10.1007/s00259-016-3591-2

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - FM/MFT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/34
Carregar mais